Source: Eur Respir Rev 2013; 22: 515-525
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Schwaiger Johannes P., Khanna Dinesh, Gerry Coghlan J.. Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations. Eur Respir Rev 2013; 22: 515-525

Member's Comments

No comment yet.

Related content which might interest you: Audit of disease targeted therapies in adult patients with pulmonary arterial hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening Source: Eur Respir Rev 2011; 20: 270-276 Year: 2011 Characteristics of Japanese elderly patients with pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Identifying early pulmonary arterial hypertension in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018 Year: 2018 Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018 Year: 2018 The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Screening for biomarkers in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Identification of treatment goals in paediatric pulmonary arterial hypertension Source: Eur Respir J 2014; 44: 1616-1626 Year: 2014 Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease in the French PAH registry Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 A screening protocol for pulmonary hypertension in systemic sclerosis identifies patients with pulmonary hypertension on exercise Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Novel biomarkers in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort Source: Eur Respir J, 49 (5) 1602275; 10.1183/13993003.02275-2016 Year: 2017 Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Exercise pathophysiology in patients with pulmonary arterial hypertension Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007 Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Treatment of pulmonary arterial hypertension in elderly and very elderly patients Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012